Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
biotech
bluebird bio
boston
boston blog main
boston top stories
clinical trials
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
joshua brumm
kaleido biosciences
life sciences
1
×
muscular dystrophy
myotonic dystrophy type 1
national blog main
national top stories
new york blog main
rare disease drugs
1
×
romesh subramanian
san diego blog main
san francisco blog main
susanna high
1
×
vertex pharmaceuticals
What
ago
1
×
biotechs
considering
data
diseases
drug
dyne
early
expected
experimental
eyes
genetic
having
1
×
humans
ipo
ipos
long
medicines
muscle
rare
reach
therapeutics
1
×
worked
Language
unset
Current search:
therapeutics
×
ago
×
" life sciences "
×
having
×
" susanna high "
×
" rare disease drugs "
×
@xconomy.com
4 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases